GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » PB Ratio

ANG Lifesciences India (BOM:540694) PB Ratio : 0.79 (As of Jun. 08, 2024)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-08), ANG Lifesciences India's share price is ₹51.72. ANG Lifesciences India's Book Value per Share for the quarter that ended in Dec. 2023 was ₹65.69. Hence, ANG Lifesciences India's PB Ratio of today is 0.79.

Good Sign:

ANG Lifesciences India Ltd stock PB Ratio (=0.8) is close to 3-year low of 0.8

The historical rank and industry rank for ANG Lifesciences India's PB Ratio or its related term are showing as below:

BOM:540694' s PB Ratio Range Over the Past 10 Years
Min: 0.56   Med: 1.08   Max: 10.04
Current: 0.8

During the past 11 years, ANG Lifesciences India's highest PB Ratio was 10.04. The lowest was 0.56. And the median was 1.08.

BOM:540694's PB Ratio is ranked better than
85.99% of 949 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs BOM:540694: 0.80

During the past 12 months, ANG Lifesciences India's average Book Value Per Share Growth Rate was -5.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 35.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 32.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 50.50% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of ANG Lifesciences India was 95.20% per year. The lowest was 21.50% per year. And the median was 41.55% per year.

Back to Basics: PB Ratio


ANG Lifesciences India PB Ratio Historical Data

The historical data trend for ANG Lifesciences India's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India PB Ratio Chart

ANG Lifesciences India Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.45 1.07 2.90 1.15

ANG Lifesciences India Quarterly Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.15 - 1.08 -

Competitive Comparison of ANG Lifesciences India's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANG Lifesciences India's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's PB Ratio distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's PB Ratio falls into.



ANG Lifesciences India PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

ANG Lifesciences India's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=51.72/65.687
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


ANG Lifesciences India  (BOM:540694) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


ANG Lifesciences India PB Ratio Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ANG Lifesciences India (BOM:540694) Business Description

Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.

ANG Lifesciences India (BOM:540694) Headlines

No Headlines